CNS Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q4 2019 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
CNS Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2019 to Q3 2024.
  • CNS Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 14, 2024 was 57.5M shares, a 995% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 57.5M +52.2M +995% Nov 14, 2024 10-Q 2024-11-14
Q2 2024 32.1M +27.9M +665% Aug 14, 2024 10-Q 2024-08-14
Q1 2024 10.6M +8.41M +378% Apr 1, 2024 10-K 2024-04-01
Q3 2023 5.25M -34.8M -86.9% Nov 14, 2023 10-Q 2023-11-14
Q2 2023 4.2M -35.8M -89.5% Aug 11, 2023 10-Q 2023-08-14
Q1 2023 2.23M -37.8M -94.4% Mar 29, 2023 10-K 2023-03-31
Q3 2022 40M +12.1M +43.4% Nov 10, 2022 10-Q 2022-11-10
Q2 2022 40M +12.6M +45.8% Aug 12, 2022 10-Q 2022-08-12
Q1 2022 40M +14.7M +57.9% Mar 3, 2022 10-K 2022-03-03
Q3 2021 27.9M +11.3M +67.7% Nov 12, 2021 10-Q 2021-11-12
Q2 2021 27.5M +11M +66.9% Aug 12, 2021 10-Q 2021-08-13
Q1 2021 25.4M +8.91M +54.2% May 10, 2021 10-Q 2021-05-13
Q4 2020 25.3M +8.85M +53.8% Feb 12, 2021 10-K 2021-02-12
Q3 2020 16.7M Nov 12, 2020 10-Q 2020-11-12
Q2 2020 16.5M Aug 10, 2020 10-Q 2020-08-10
Q1 2020 16.5M Mar 11, 2020 10-K 2020-03-12
Q4 2019 16.5M Dec 20, 2019 10-Q 2019-12-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.